Clinical Trial Update: PVAG-14 Pilot for Intermediate Stages Hodgkin Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of PVAG-14 for intermediate-stage Hodgkin lymphoma sponsored by the University of Cologne has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• PVAG-14

Snippet

Sponsor: University of Cologne | Conditions: Hodgkin Lymphoma | Phase 2 | Status: TERMINATED